Does peripheral T-lymphocyte subpopulations correlate with hepatitis B virus...
Hepatitis B virus (HBV) infection is a dynamic process with variable biochemical, virological and histological profiles at different stages of the infection, depending on host and viral factors....
View ArticleMen experience sexual dysfunction during hepatitis C therapy
Sexual impairment is common among men with chronic hepatitis C undergoing antiviral therapy, according to a new study in Gastroenterology, the official journal of the American Gastroenterological...
View ArticleTriple-combo drug shows promise against antiviral-resistant H1N1, researcher...
An experimental drug cocktail that includes three prescriptions now widely available offers the best hope in developing a single agent to treat drug-resistant H1N1 swine flu, says a virology researcher...
View ArticleAlarming trend -- antiviral therapy to treat hepatitis C is declining in the US
Researchers from the University of Michigan determined that only 663,000 of the approximately 3.9 million Americans with hepatitis C virus (HCV) infection received antiviral therapy between 2002 and...
View ArticleTransplant infectious disease experts provide pandemic guidance
Surgeons and other healthcare professionals specialising in solid organ transplants have been issued with expert advice to guide them through the complex clinical issues posed by the global H1N1 (swine...
View Article'Rational drug design' identifies fragments of FDA-approved drugs relevant to...
A massive, data-crunching computer search program that matches fragments of potential drug molecules to the known shapes of viral surface proteins has identified several FDA-approved drugs that could...
View ArticleAntiviral therapy during compensated cirrhosis most cost-effective approach
Researchers at the UCLA Medical Center found that antiviral therapy during compensated cirrhosis, when compared with all other strategies, is the most cost-effective approach to treating patients with...
View ArticleA nutritional supplement for treating chronic hepatitis C: Viusid
A research team from Cuba investigated the efficacy of Viusid, a nutritional supplement, as an antioxidant and an immunomodulator in patients with chronic hepatitis C. Their results showed that...
View ArticleSilencing hepatitis B virus prevent recurrence of liver cancer
Previous studies have shown that antiviral treatment reduces the incidence of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). But now, researchers from the Division of...
View ArticleAntiviral therapy associated with fewer recurring eye problems from herpes...
Taking oral antiviral medications following infection with the herpes simplex virus may be associated with a reduced risk of recurring eye-related manifestations of the disease, according to a report...
View ArticleHow H1N1 differs from other viruses as a respiratory illness
The 2009/2010 Influenza A (H1N1) is one of several viruses responsible for respiratory-related infections. A new study from Rhode Island Hospital examined patients with viruses and found distinguishing...
View ArticleInfluenza virus strains show increasing drug resistance and ability to spread
Two new studies raise public health concerns about increasing antiviral resistance among certain influenza viruses, their ability to spread, and a lack of alternative antiviral treatment options. The...
View ArticleResearchers identify gene variants linked to hepatitis C treatment-related...
In two recent studies, researchers have identified two functional variants in the inosine triphosphatase (ITPA) gene that protect patients with hepatitis C virus (HCV) against anemia brought on by...
View ArticleLack of health insurance limits hepatitis C patients' access to latest...
New research has determined that patients in the U.S. with hepatitis C virus (HCV) are twice as likely to not have health insurance coverage compared with those without the disease. In fact researchers...
View ArticleDrug to fight tumors also fights the flu and possibly other viruses
Ever get a flu shot and still get the flu? If so, there's new hope for flu-free winters in the years to come thanks to a new discovery by researchers who found that a drug called DMXAA, originally...
View ArticleFrom blank round to a potently active substance?
A long-forgotten candidate for antiviral therapy is undergoing a renaissance: Since the 1970s, the small molecule CMA has been considered a potent agent against viral infections, yet it was never...
View ArticleNew compound could be alternative strategy for preventing HIV infection
With the help of effective drug therapies, HIV patients are living longer, healthier lives. Now, researchers want to improve these drug therapies and develop alternative preventative strategies, such...
View ArticleScientists measure energy released from a virus during infection
Within a virus's tiny exterior is a store of energy waiting to be unleashed. When the virus encounters a host cell, this pent-up energy is released, propelling the viral DNA into the cell and turning...
View ArticleResearchers identify key molecular step to fighting off viruses
UT Southwestern Medical Center researchers have determined how a protein that normally latches onto molecules inside cells and marks them for destruction also gives life to the body's immune response...
View ArticleScientists devise strategy in bid to beat viruses
Scientists have developed a new way to target viruses which could increase the effectiveness of antiviral drugs.
View ArticlePutting the brakes on drug-resistant HIV
(PhysOrg.com) -- HIV-1 protease inhibitors were added as a component of highly active antiretroviral therapy (HAART) in the mid-1990s, and have played a key role in that treatment regimen ever since....
View ArticleNew antiviral drugs could come from DNA 'scrunching'
Evidence of DNA "scrunching" may one day lead to a new class of drugs against viruses, according to a research team from the Perelman School of Medicine at the University of Pennsylvania, the Georgia...
View Article
